New molecular target for lung cancer using PPAR-gamma
Project/Area Number |
25462175
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Respiratory surgery
|
Research Institution | Kyoto Prefectural University of Medicine (2015-2016) Osaka University (2013) |
Principal Investigator |
Inoue Masayoshi 京都府立医科大学, 医学(系)研究科(研究院), 教授 (10379232)
|
Co-Investigator(Kenkyū-buntansha) |
南 正人 大阪大学, 医学部附属病院, 准教授 (10240847)
奥村 明之進 大阪大学, 医学系研究科, 教授 (40252647)
澤端 章好 大阪大学, 医学系研究科, 招へい教授 (50403184)
舟木 壮一郎 大阪大学, 医学系研究科, 講師 (50464251)
中桐 伴行 大阪大学, 医学系研究科, 招へい教員 (70528710)
新谷 康 大阪大学, 医学系研究科, 准教授 (90572983)
川村 知裕 大阪大学, 医学系研究科, 助教 (30528675)
|
Project Period (FY) |
2013-04-01 – 2017-03-31
|
Project Status |
Completed (Fiscal Year 2016)
|
Budget Amount *help |
¥4,940,000 (Direct Cost: ¥3,800,000、Indirect Cost: ¥1,140,000)
Fiscal Year 2015: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
Fiscal Year 2014: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2013: ¥2,860,000 (Direct Cost: ¥2,200,000、Indirect Cost: ¥660,000)
|
Keywords | 肺癌 / PPAR-gamma / 上皮間葉移行 / PPARγ / 癌間質 |
Outline of Final Research Achievements |
PPAR-gamma, an intra-nuclear protein, has a potential role for anti-inflammation and anti-tumor effect. We assessed the anti-tumor role caused by the control of epithelial-mesenchymal transition using PPAR-gamma agonists in lung cancer. The epithelial-mesenchymal transition was slightly suppressed by tBHQ, an activator of Nrf2 which regulates PPAR-gamma expression in vitro. Additionally, pirfenidone, an anti-fibrotic agent, showed suppression both of epithelial-mesenchymal transition and cancer cell growth.
|
Report
(4 results)
Research Products
(6 results)